Stock 2276 SHANGHAI CONANT OPTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Conant Optical Co., Ltd.

Equities

2276

CNE100004Z14

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:42 28/06/2024 BST 		5-day change 1st Jan Change
12.36 HKD +2.83% Intraday chart for Shanghai Conant Optical Co., Ltd. -2.37% +75.07%
06-04 Shanghai Conant Optical Co., Ltd. Approves the Final Cash Dividend for the Year Ended December 31, 2023, Payable on or Before 2 August 2024 CI
05-31 Shanghai Conant Optical Buys Wealth Management Product MT

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 1,557 1,778 2,737 4,773 - -
Enterprise Value (EV) 1 1,557 1,778 2,737 4,773 4,773 4,773
P/E ratio 6.19 x 7.19 x 8.33 x 11.4 x 10.2 x 8.75 x
Yield - - 3.12% 2.1% 2.48% -
Capitalization / Revenue - - 1.56 x 2.37 x 2.1 x 1.9 x
EV / Revenue - - 1.56 x 2.37 x 2.1 x 1.9 x
EV / EBITDA - - - - - -
EV / FCF - - 7.73 x 18.4 x 18.3 x -
FCF Yield - - 12.9% 5.43% 5.47% -
Price to Book - - 1.96 x 2.78 x 2.32 x 1.92 x
Nbr of stocks (in thousands) 426,600 426,600 426,600 426,600 - -
Reference price 2 3.650 4.169 6.417 11.19 11.19 11.19
Announcement Date 25/03/22 17/03/23 27/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - 1,760 2,014 2,275 2,509
EBITDA - - - - - -
EBIT 1 - - 380 499 546.5 658
Operating Margin - - 21.59% 24.77% 24.02% 26.23%
Earnings before Tax (EBT) 1 - - 393 488.5 571.5 638
Net income 1 183.5 248.6 327 417.2 467.8 544.4
Net margin - - 18.58% 20.71% 20.56% 21.7%
EPS 2 0.5900 0.5800 0.7700 0.9800 1.097 1.279
Free Cash Flow 1 - - 354.2 259 261 -
FCF margin - - 20.13% 12.86% 11.47% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - 108.32% 62.07% 55.79% -
Dividend per Share 2 - - 0.2000 0.2345 0.2770 -
Announcement Date 25/03/22 17/03/23 27/03/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - 354 259 261 -
ROE (net income / shareholders' equity) - - 25.7% 24.3% 23.2% 21.8%
ROA (Net income/ Total Assets) - - 17.3% 17.6% 17.4% 17.4%
Assets 1 - - 1,886 2,371 2,696 3,129
Book Value Per Share 2 - - 3.270 4.030 4.830 5.830
Cash Flow per Share 2 - - - 0.8500 0.9600 1.070
Capex 1 - - 126 100 115 93
Capex / Sales - - 7.19% 4.96% 5.04% 3.71%
Announcement Date 25/03/22 17/03/23 27/03/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
11.19 CNY
Average target price
12.47 CNY
Spread / Average Target
+11.47%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+75.07% 657M
ESSILORLUXOTTICA Stock EssilorLuxottica
+11.62% 98.99B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-7.39% 17.45B
AUTEK CHINA INC. Stock Autek China Inc.
-29.23% 1.97B
WARBY PARKER INC. Stock Warby Parker Inc.
+15.25% 1.93B
PEGAVISION CORPORATION Stock Pegavision Corporation
+20.93% 1.15B
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-11.01% 641M
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-47.06% 612M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-43.76% 627M
VISCO VISION INC. Stock Visco Vision Inc.
+28.34% 539M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. 2276 Stock
  4. Financials Shanghai Conant Optical Co., Ltd.